103 related articles for article (PubMed ID: 16445664)
81. Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in 27 Cases.
Zhang Z; Gao P; Bao Z; Zeng L; Yao J; Chai D; Li T
Front Oncol; 2021; 11():732782. PubMed ID: 34926250
[TBL] [Abstract][Full Text] [Related]
82. A clear cancer cell line (150057) derived from human endometrial carcinoma harbors two novel mutations.
Chang YH; Ding DC
BMC Cancer; 2020 Nov; 20(1):1058. PubMed ID: 33143664
[TBL] [Abstract][Full Text] [Related]
83. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
[TBL] [Abstract][Full Text] [Related]
84. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
Heckl M; Schmoeckel E; Hertlein L; Rottmann M; Jeschke U; Mayr D
PLoS One; 2018; 13(2):e0192881. PubMed ID: 29451900
[TBL] [Abstract][Full Text] [Related]
85. Clear cell carcinoma of ovary and uterus.
Glasspool RM; McNeish IA
Curr Oncol Rep; 2013 Dec; 15(6):566-72. PubMed ID: 24114188
[TBL] [Abstract][Full Text] [Related]
86. The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.
Fadare O; Gwin K; Desouki MM; Crispens MA; Jones HW; Khabele D; Liang SX; Zheng W; Mohammed K; Hecht JL; Parkash V
Mod Pathol; 2013 Aug; 26(8):1101-10. PubMed ID: 23524907
[TBL] [Abstract][Full Text] [Related]
87. Cervical adenocarcinoma with clear cell morphology. report of six cases and literature review.
Kondi-Pafiti A; Kairi-Vassilatou E; Bakalianou K; Iavazzo C; Kleanthis Ch; Hasiakos D; Liapis A
Eur J Gynaecol Oncol; 2011; 32(1):107-10. PubMed ID: 21446339
[TBL] [Abstract][Full Text] [Related]
88. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
[TBL] [Abstract][Full Text] [Related]
89. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
[TBL] [Abstract][Full Text] [Related]
90. E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium.
Holcomb K; Delatorre R; Pedemonte B; McLeod C; Anderson L; Chambers J
Obstet Gynecol; 2002 Dec; 100(6):1290-5. PubMed ID: 12468176
[TBL] [Abstract][Full Text] [Related]
91. Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters.
Kayaselcuk F; Erkanli S; Bolat F; Seydaoglu G; Kuscu E; Demirhan B
Int J Gynecol Cancer; 2006; 16(1):402-8. PubMed ID: 16445666
[TBL] [Abstract][Full Text] [Related]
92. The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.
Nishimura S; Ito YM; Tsuda H; Ohnishi Y; Kataoka F; Nomura H; Chiyoda T; Suzuki A; Susumu N; Aoki D; Hatae M
Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):67-72. PubMed ID: 19815329
[TBL] [Abstract][Full Text] [Related]
93. Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma.
Arai T; Watanabe J; Kawaguchi M; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
Int J Gynecol Cancer; 2006; 16(1):391-5. PubMed ID: 16445664
[TBL] [Abstract][Full Text] [Related]
94. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
Wu HW; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
[No Abstract] [Full Text] [Related]
95.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
96.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
